Contributed By Jones Day
In Japan, pharmaceutical companies may initiate civil litigation proceedings against their competitors before courts for certain types of advertising infringements based on the UCPA.
Under the UCPA, a company whose business interests have been infringed or are likely to be infringed by a competitor’s
The company may also claim damages to its business interests resulting from intentional or negligent infringement related to the above conduct.
For example, a pharmaceutical company may file a lawsuit in Japanese court seeking an injunction and/or compensation of damages against a competitor if the competitor creates an advertisement containing falsehoods or slander regarding the pharmaceutical company’s products.
Kamiyacho Prime Place
1-17, Toranomon 4-chome